These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34985196)

  • 1. Sex-dependent influence of postweaning environmental enrichment in Angelman syndrome model mice.
    Cosgrove JA; Kelly LK; Kiffmeyer EA; Kloth AD
    Brain Behav; 2022 Feb; 12(2):e2468. PubMed ID: 34985196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel
    Sonzogni M; Wallaard I; Santos SS; Kingma J; du Mee D; van Woerden GM; Elgersma Y
    Mol Autism; 2018; 9():47. PubMed ID: 30220990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.
    Huang HS; Burns AJ; Nonneman RJ; Baker LK; Riddick NV; Nikolova VD; Riday TT; Yashiro K; Philpot BD; Moy SS
    Behav Brain Res; 2013 Apr; 243():79-90. PubMed ID: 23295389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersociability in the Angelman syndrome mouse model.
    Stoppel DC; Anderson MP
    Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model.
    Milazzo C; Mientjes EJ; Wallaard I; Rasmussen SV; Erichsen KD; Kakunuri T; van der Sman ASE; Kremer T; Miller MT; Hoener MC; Elgersma Y
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34369389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
    Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
    Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral Evaluation of Angelman Syndrome Mice at Older Ages.
    Dutta R; Crawley JN
    Neuroscience; 2020 Oct; 445():163-171. PubMed ID: 31730795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult
    Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
    J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a TrkB agonist on spatial and motor learning in the
    Schultz MN; Crawley JN
    Learn Mem; 2020 Sep; 27(9):346-354. PubMed ID: 32817301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Dependent Sensory Phenotypes and Related Transcriptomic Expression Profiles Are Differentially Affected by Angelman Syndrome.
    Koyavski L; Panov J; Simchi L; Rayi PR; Sharvit L; Feuermann Y; Kaphzan H
    Mol Neurobiol; 2019 Sep; 56(9):5998-6016. PubMed ID: 30706369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Nociception in Angelman Syndrome Model Mice.
    McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
    J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the
    Syding LA; Kubik-Zahorodna A; Nickl P; Novosadova V; Kopkanova J; Kasparek P; Prochazka J; Sedlacek R
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.
    Copping NA; Silverman JL
    Mol Autism; 2021 Feb; 12(1):9. PubMed ID: 33549123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
    Silva-Santos S; van Woerden GM; Bruinsma CF; Mientjes E; Jolfaei MA; Distel B; Kushner SA; Elgersma Y
    J Clin Invest; 2015 May; 125(5):2069-76. PubMed ID: 25866966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
    Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
    PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
    Sonzogni M; Hakonen J; Bernabé Kleijn M; Silva-Santos S; Judson MC; Philpot BD; van Woerden GM; Elgersma Y
    Mol Autism; 2019; 10():23. PubMed ID: 31143434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome.
    Sidorov MS; Judson MC; Kim H; Rougie M; Ferrer AI; Nikolova VD; Riddick NV; Moy SS; Philpot BD
    J Neurosci; 2018 Mar; 38(11):2671-2682. PubMed ID: 29431654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences.
    Grier MD; Carson RP; Lagrange AH
    Behav Brain Res; 2015 Sep; 291():260-267. PubMed ID: 26028516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.
    Leach PT; Crawley JN
    Genes Brain Behav; 2018 Jul; 17(6):e12452. PubMed ID: 29266714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.